Benchtop Bioreactors Market Report 2026

Benchtop Bioreactors Market Overview

• Benchtop Bioreactors market size has reached to $1.08 billion in 2025 • Expected to grow to $1.75 billion in 2030 at a compound annual growth rate (CAGR) of 10.1% • Growth Driver: Rising Adoption Of Gene Therapies Fueling The Growth Of The Market Due To Advancements In Genetic Sequencing • Market Trend: Modular Bioreactors Enable Seamless Parallel Operation and Flexible Expansion • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Benchtop Bioreactors Market?

Benchtop bioreactors are small-scale, laboratory vessels designed for the controlled cultivation of cells, microorganisms, or tissues. They enable precise regulation of environmental factors such as temperature, pH, and oxygen to optimize growth and product yield. These bioreactors support research and development by providing a controlled environment for efficient biological processes and product development. The main types of benchtop bioreactors are swing-style bioreactors, stirred-tank bioreactors, wave-mixed bioreactors, airlift bioreactors, and bubble column bioreactors. Swing-style bioreactors refer to bioreactors that use a rocking or swinging motion to gently mix and aerate cell cultures, providing a controlled environment for cell growth. These bioreactors can be classified by control type into automated bioreactors, manual bioreactors, continuous bioreactors, and batch bioreactors, and are made from materials such as stainless steel, glass, plastic, and composite materials. These bioreactors find applications in research and development, process development, bioproduction, quality control, and training and education, serving end users such as pharmaceutical companies, biotechnology companies, academic and research institutes, contract research organizations (CROs), and food and beverage industry.

What Is The Benchtop Bioreactors Market Growth Forecast?

The benchtop bioreactors market size is expected to see rapid growth in the next few years. It will grow to $1.75 billion in 2030 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to expansion of biologics and biosimilar development, adoption of automated and continuous bioreactors, rising focus on personalized medicine research, increasing collaboration with cros, advancements in bioprocessing technologies. Major trends in the forecast period include rising adoption of benchtop bioreactors in research and development, growing demand for single-use and modular bioreactor systems, increasing focus on process optimization and yield improvement, expansion of cell culture and microbial fermentation studies, rising use of benchtop bioreactors in training and academic research.

Global Benchtop Bioreactors Market Segmentation

1) By Type: Swing-Style Bioreactors, Stirred-Tank Bioreactors, Wave-Mixed Bioreactors, Airlift Bioreactors, Bubble Column Bioreactors 2) By Control Type: Automated Bioreactors, Manual Bioreactors, Continuous Bioreactors, Batch Bioreactors 3) By Material: Stainless Steel, Glass, Plastic, Composite Materials 4) By Application: Research And Development, Process Development, Bioproduction, Quality Control, Training And Education 5) By End User: Pharmaceutical Companies, Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations (CROs), Food And Beverage Industry Subsegments: 1) By Swing-Style Bioreactors: Single-Use Swing Bioreactors, Multi-Use Swing Bioreactors, Compact Swing Bioreactors, Automated Swing Bioreactors 2) By Stirred-Tank Bioreactors: Single-Use Stirred-Tank Bioreactors, Glass Stirred-Tank Bioreactors, Stainless-Steel Stirred-Tank Bioreactors, Modular Stirred-Tank Bioreactors, Automated Stirred-Tank Bioreactors 3) By Wave-Mixed Bioreactors: Single-Use Wave-Mixed Bioreactors, Dual-Motion Wave-Mixed Bioreactors, Automated Wave-Mixed Bioreactors, Compact Wave-Mixed Bioreactors 4) By Airlift Bioreactors: Internal Loop Airlift Bioreactors, External Loop Airlift Bioreactors, Single-Use Airlift Bioreactors 5) By Bubble Column Bioreactors: Vertical Bubble Column Bioreactors, Single-Use Bubble Column Bioreactors, Gas-Lift Bubble Column Bioreactors, Automated Bubble Column Bioreactors

What Is The Driver Of The Benchtop Bioreactors Market?

The rising adoption of gene therapies is expected to propel the growth of the benchtop bioreactors market going forward. Gene therapy refers to a medical technique that involves modifying or replacing defective genes to treat or prevent diseases. The increasing demand for gene therapy is due to advancements in genetic sequencing and diagnostics, which enable precise identification of disease-causing genes for targeted treatment. Benchtop bioreactors accelerate gene therapies by enabling precise control and efficient production of gene-modified cells. They support rapid research and small-scale manufacturing, improving process speed and consistency. For instance, in December 2024, according to the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, the Food and Drug Administration (FDA) approved six gene therapy products in 2023, up from five approvals in 2022. Therefore, the rising adoption of gene therapies is driving the growth of the benchtop bioreactors industry.

Key Players In The Global Benchtop Bioreactors Market

Major companies operating in the benchtop bioreactors market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE Healthcare, Sartorius AG, Eppendorf AG, Solaris Biotech Solutions, IKA-Werke GmbH And Co. KG, GPC Bio USA, Praj HiPurity Systems Limited., PBS Biotech Inc., Bioengineering AG, Broadley‑James Ltd., Infors HT, Solida Biotech, Bbi-biotech GmbH, Applikon Biotechnology B.V., Labfirst Scientific Instruments Co. Ltd, Pharsol Ltd., Uma Pharmatech Machinery

Global Benchtop Bioreactors Market Trends and Insights

Major companies operating in the benchtop bioreactors market are focusing on developing innovative solutions, such as benchtop fermenters, to enhance precise control and scalability for research and small-scale production. Benchtop fermenters are compact, laboratory-scale bioreactors designed for controlled cultivation of microorganisms or cells to support research and small-scale production. For instance, in September 2024, VFL Sciences Private Limited, an India-based biotechnology equipment manufacturer, launched the GreatFlo range of benchtop fermenters or bioreactors. This versatile and modular product line is engineered for easy scale-up and consistent reproducibility in fermentation and cell culture applications. These fermenters support seamless parallel operation with flexible expansion options from 2 to 16 vessels, each offering a working volume of 200-500 ml. It is equipped with Peltier-controlled heating and cooling, exhaust condensers, and software compliant with 21 CFR Part 11 and provides precise regulation of agitation, pH, dissolved oxygen, and individual gas mixing.

What Are Latest Mergers And Acquisitions In The Benchtop Bioreactors Market?

In May 2024, Advanced Bioprocessing Equipment Corporation (ABEC) Inc., a US-based biopharmaceutical manufacturing company, acquired the bioreactor technology of Membio Inc. for an undisclosed amount. With this acquisition, ABEC, Inc. aims to strengthen its cell-culture manufacturing footprint by integrating Membio’s innovative benchtop bioreactor platform. Membio Inc. is a Canada‑based biotech company focused on developing scalable cell‑culture systems that mimic human physiological conditions.

Regional Insights

North America was the largest region in the benchtop bioreactors market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Benchtop Bioreactors Market?

The benchtop bioreactors market consists of sales of automated benchtop bioreactors, modular and scalable systems, single-use bioreactors, and micro-bioreactors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Benchtop Bioreactors Market Report 2026?

The benchtop bioreactors market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the benchtop bioreactors industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.